KJ

Kavitha Joginapalli

Director Designated Partner DIN 06964357
DIN 06964357 First appointment Nov 2014 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Nov 2014
Shareholding value β€’β€’β€’β€’ Premium profile

About Kavitha Joginapalli

Data last updated:

Kavitha Joginapalli was a Designated Partner at Genresearch Pharma Llp (2020–2021) and Director at Srinidhi Lifesciences Private Limited (from 2014). The companies operate in Chemicals.

DIN 06964357
Primary Designation Designated Partner
Industry Chemicals
First Appointment 13 Nov 2014
Oldest Company Age 11 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner18 May 20202020Strike Off
Director13 Nov 20142014Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Srinidhi Lifesciences Private Limited
Genresearch Pharma Llp
Premium access

Shareholding and investment profile for Kavitha Joginapalli

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kavitha Joginapalli

Kavitha Joginapalli was first appointed on 13 Nov 2014 as Director at Srinidhi Lifesciences Private Limited. The most recent appointment on record is 18 May 2020 at Genresearch Pharma Llp.

Kavitha Joginapalli held 2 earlier board appointments: Genresearch Pharma Llp (Designated Partner, 18 May 2020 to 28 Jul 2021); Srinidhi Lifesciences Private Limited (Director, from 13 Nov 2014).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available